House Bill No. by Representative Brown amends R.S. 22:1657(B)(1) to enhance regulations surrounding pharmacy benefit managers (PBMs) in Louisiana. The bill introduces new prohibitions that prevent PBMs, insurers, or third-party administrators from altering health benefit plans based on information regarding financial or product assistance for prescription drugs. Specifically, it prohibits these entities from setting or conditioning the terms of a health benefit plan based on such information, ensuring that patients have access to all relevant options when acquiring their prescription medications.

Additionally, the bill clarifies that pharmacy benefit managers cannot contractually restrict pharmacies or pharmacists from informing patients about their options, including the cost and clinical efficacy of more affordable alternatives, as well as the possibility of paying cash if it is less than the insurance copayment or deductible. This legislative change aims to promote transparency and patient choice in the prescription drug market, ultimately benefiting consumers by ensuring they are well-informed about their medication options.

Statutes affected:
HB509 Original: 22:1657(B)(1)